Israel - Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use
Since 2014, Israel Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use grew 1.2% year on year. In 2019, the country was number 21 comparing other countries in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use with 65.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Israel is overtaken by Finland, which was number 20 with 69.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Estonia at 55 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Netherlands topped the ranking with 131.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, +3.9% compared to 2018. Spain, United Kingdom and Iceland respectively ranked number 2, 3 and 4 in this ranking. Canada recorded the best 5 years average growth at +11.3% per year, while Austria recorded the worst performance at -14% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 65.80 |
| 2018 | 63.70 |
| 2017 | 65.30 |
| 2016 | 65.40 |
| 2015 | 64.40 |
How does Israel rank in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Netherlands
|
132 | 2019 | +3.9 % | +3.5 % | View data | |
| 2 |
#2
Spain
|
129 | 2019 | +2.8 % | +0.6 % | View data | |
| 20 |
#20
Finland
|
69 | 2019 | +3.3 % | +0.9 % | View data | |
| 21 |
#21
Israel
|
66 | 2019 | +3.3 % | +1.2 % | View data | |
| 22 |
#22
Estonia
|
55 | 2019 | +7.2 % | +7.2 % | View data | |